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2018 Hospital Profile
Overview / Size Payer Mix
Hospital System Affiliation: Public Payer Mix:
Hospital System Surplus (Loss) in FY18: CY17 Commercial Statewide Relative Price:
Change in Ownership (FY14-18): Top 3 Commercial Payers:
Total Staffed Beds:
Change FY17-FY18:
Financial Emergency Department Visits in FY18:
Inpatient NPSR per CMAD: Change FY17-FY18:
Change FY17-FY18: Outpatient Visits in FY18:
`
For descriptions of the metrics, please see the technical appendix.  
What proportion of adult patient discharges from this hospital resulted in 
a readmission at any hospital within 30 days, and how does this 
compare to the state average?
How many central line-associated blood stream infections (CLABSI), 
catheter-associated urinary tract infections (CAUTI), and surgical site 
infections (SSI) after colon surgery did patients get at this hospital 
compared to what was expected based on the hospital's characteristics 
and case mix?
What were the most common inpatient cases (DRGs) treated at the 
hospital in FY18? What proportion of the region’s cases did this hospital 
treat for each service? 
Where did most of the hospital's inpatients reside? What proportion of 
each community's total discharges was attributed to this hospital?
 - - - Hospital  (9,769) = 3%  of total regional  discharges 
MELROSEWAKEFIELD HOSPITAL
Medford & Melrose, MA
Community-High Public Payer Hospital
Metro Boston
MelroseWakefield Hospital, which includes Lawrence Memorial Hospital and Melrose-Wakefield Hospital campuses, is a mid-size, non-profit community High 
Public Payer (HPP) hospital located in the Metro Boston region. Between FY14 and FY18, the volume of inpatient discharges at the hospital decreased by 
17.2% compared to a median increase of 3.1% at cohort hospitals. Outpatient visits decreased 19.1% for the hospital between FY14 and FY18, compared to 
a median increase of 5.0% for its peer cohort. MelroseWakefield Healthcare reported a profit of $20.1M in FY18 and a total margin of 7.9%.
Quality
Early Elective Deliveries Rate: 
Change FY14-FY18 (percentage points):
$20,094,000
Total Revenue in FY18: $253,632,000
-12.0%Change FY17-FY18:
Outpatient Revenue in FY18:
0.0%
15.8%
-0.7
Readmission Rate in FY18:
Blue Cross Blue Shield of Massachusetts
Tufts Associated HMO, Inc.
Harvard Pilgrim Health Care
Wellforce - 2017
162, mid-size acute hospital
88.6%, > cohort avg. (67%)
63.2% HPP Hospital
-11.1%
Utilization
Inpatient Discharges in FY18:
Wellforce
44,279
0.92
9,769
-5.4%$11,379
$38,459,000
30%:70%
$126,893,905
Inpatient:Outpatient Revenue in FY18:
Total Surplus (Loss) in FY18:
Change FY17-FY18:
% Occupancy:
Special Public Funding: CHART^, ICB°
Not Applicable
Case Mix Index: 0.91, < cohort avg. (0.93); < statewide (1.14)
Trauma Center Designation:
-11.6%
450,46517.0%
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Cesarean Delivery (245)
Cardiac Arrhythmia  (245)
Maj Depressive Disorders (248)
Renal Failure (305)
COPD (341)
Other Pneumonia (351)
Septicemia Infections (393)
Vaginal Delivery (533)
Heart Failure (536)
Normal Neonate Birth (746)
Discharges by DRG
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Somerville MA (166)
Lynn MA (208)
Everett MA (394)
Revere MA (462)
Stoneham MA (507)
Wakefield MA (909)
Saugus MA (1,028)
Melrose MA (1,128)
Medford MA (1,171)
Malden MA (1,560)
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Key:
Hospital
Cohort: Community-High Public Payer Hospital Peer Cohort
For descriptions of the metrics, please see the technical appendix.
* High Public Payer Hospitals (HPP) receive a minimum of 63% of gross patient service revenue from public payers.
° For more information on Infrastructure and Capacity Building (ICB) special funding, please contact the Massachusetts Executive Office of Health and Human Services (EOHHS).
^ For more information on Community Hospital Acceleration, Revitalization and Transformation (CHART) special funding, please contact the Health Policy Commission (HPC).
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How has the volume of the hospital's inpatient discharges changed 
compared to FY14, and how does this compare to the hospital's peer 
cohort median? (FY14=100)
How has the volume of the hospital's outpatient visits changed 
compared to FY14, and how does this compare to the hospital's peer 
cohort median? (FY14=100)
What was the hospital's net inpatient service revenue per case mix 
adjusted discharge between FY14 and FY18, and how does this 
compare to the hospital's peer cohort median?
How has the hospital's total outpatient revenue changed compared to 
FY14, and how does this compare to the hospital's peer cohort median? 
(FY14=100)
How have the hospital's total revenue and costs changed between FY14 
and FY18?
Total Profit (Loss) 13.5$     13.0$     (1.9)$     7.9$       
265.0$   
Total Revenue 266.3$   271.4$   265.4$   272.8$   
Total Costs 252.8$   258.4$   267.3$   
253.6$   
233.5$   
20.1$     
11.6$     
 Operating Revenue
Non-Operating 
Revenue
9.2$       9.0$       7.7$       8.2$       
What were the hospital's total margin and operating margins between 
FY14 and FY18, and how do these compare to the hospital's peer 
cohort medians?
Revenue, Cost, & Profit/Loss (in millions)
FY 2014 2015 2016 2017
257.0$   262.4$   257.7$   261.2$   245.4$   
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